Biocon clears patent hurdle for breast cancer biosimilar Pebrilzo
Genentech patent settlement clears legal hurdles for Pebrilzo; competition and pricing will determine commercial gains
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.